Argyro Repa
ScholarGPS® ID: 65588191286660
Affiliation History
Field
Medicine
Discipline
Rheumatology
Top Specialties
Arthritis | Rheumatoid Arthritis | Systemic Lupus Erythematosus | Familial Mediterranean Fever | Lupus Erythematosus | Biological Agent
Metrics Summary
Publication Count
60
Predicted Citations
831
Predicted h-index
12
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria (2024) |
EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria (2024) |
Annals of the Rheumatic Diseases, volume 83, issue 4, pages 464-474 (2024). |
14th European Lupus Meeting, Bruges, Belgium, March 19–22, 2024 (2024) |
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with ‘difficult to treat’ rheumatoid arthritis (journal article) RMD Open, volume 10, issue 1, pages e003808- (2024). |
Comorbidities Burden and Implementation of the Treat–to–Target Strategy in Predicting Real-World Patient Outcomes in Spondyloarthritides (journal article) Mediterranean Journal of Rheumatology, volume 34, issue 4, pages 581- (2023). |
Cells, volume 12, issue 24, pages 2808- (2023). |
Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors? (journal article) Journal of Clinical Medicine, volume 12, issue 21, pages 6945- (2023). |
Rheumatology International, volume 44, issue 2, pages 249-261 (2023). |
Current Psychology, volume 42, issue 20, pages 16923-16931 (2023). |
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study (journal article) Frontiers in Immunology, volume 13 (2023). |
Arthritis Research & Therapy, volume 24, issue 1 (2022). |
Journal of Clinical Medicine, volume 11, issue 15, pages 4316- (2022). |
AB0538 INCREASED BURDEN OF MENTAL DISORDERS DESPITE IMPROVEMENT IN DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A PROSPECTIVE STUDY (journal article) Annals of the Rheumatic Diseases, volume 81, issue Suppl 1, pages 1396.2-1396 (2022). |
Annals of the Rheumatic Diseases, volume 81, issue Suppl 1, pages 1314.2-1315 (2022). |
Annals of the Rheumatic Diseases, volume 81, issue Suppl 1, pages 671.1-671 (2022). |
Annals of the Rheumatic Diseases, volume 81, issue Suppl 1, pages 437-438 (2022). |
The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study (journal article) Rheumatology International, volume 42, issue 4, pages 639-650 (2022). |
Distinct Long-Term Disease Activity Trajectories Differentiate Early on Treatment with Etanercept in Both Rheumatoid Arthritis and Spondylarthritis Patients (journal article) SSRN Electronic Journal (2022). |
Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample (journal article) Lupus, volume 30, issue 14, pages 2237-2247 (2021). |